Financials Aspen Aerogels, Inc.

Equities

ASPN

US04523Y1055

Specialty Chemicals

Real-time Estimate Cboe BZX 09:40:06 2024-05-24 am EDT 5-day change 1st Jan Change
27.92 USD +1.18% Intraday chart for Aspen Aerogels, Inc. +4.59% +74.84%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 188.6 448.4 1,647 780.2 1,204 2,101 - -
Enterprise Value (EV) 1 188.1 435.6 1,647 780.2 1,180 2,140 2,429 2,532
P/E ratio -12.9 x -20.1 x -40.8 x -5.61 x -23.9 x 360 x 42.1 x 24 x
Yield - - - - - - - -
Capitalization / Revenue 1.35 x 4.47 x 13.5 x 4.33 x 5.04 x 5.32 x 3.74 x 2.95 x
EV / Revenue 1.35 x 4.34 x 13.5 x 4.33 x 4.94 x 5.41 x 4.32 x 3.55 x
EV / EBITDA -1,075 x -68.4 x -63.4 x -12.9 x -51.4 x 35.4 x 19.9 x 14.1 x
EV / FCF -59.4 x -32.7 x -50.8 x -2.86 x -5.41 x -40.3 x -12.2 x 156 x
FCF Yield -1.68% -3.06% -1.97% -34.9% -18.5% -2.48% -8.21% 0.64%
Price to Book 3.2 x 6.84 x 11.8 x 1.05 x 2.47 x 4.15 x 3.73 x 3.45 x
Nbr of stocks (in thousands) 24,300 26,868 33,079 66,173 76,318 76,161 - -
Reference price 2 7.760 16.69 49.79 11.79 15.78 27.59 27.59 27.59
Announcement Date 2/20/20 2/18/21 2/17/22 2/15/23 2/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 139.4 100.3 121.6 180.4 238.7 395.3 561.6 712.3
EBITDA 1 -0.175 -6.367 -25.98 -60.64 -22.93 60.37 121.9 179
EBIT 1 -14.16 -21.57 -40.6 -79.24 -49.2 16.4 69.49 122.3
Operating Margin -10.16% -21.51% -33.38% -43.94% -20.61% 4.15% 12.37% 17.17%
Earnings before Tax (EBT) 1 -14.56 -21.81 -37.09 -82.74 -45.81 7.195 53.61 99.44
Net income 1 -14.56 -21.81 -37.09 -82.74 -45.81 5.736 50.52 89.99
Net margin -10.45% -21.75% -30.5% -45.87% -19.19% 1.45% 8.99% 12.63%
EPS 2 -0.6000 -0.8300 -1.220 -2.100 -0.6600 0.0767 0.6556 1.148
Free Cash Flow 1 -3.166 -13.34 -32.41 -272.4 -218.1 -53.09 -199.5 16.22
FCF margin -2.27% -13.3% -26.64% -151.01% -91.35% -13.43% -35.52% 2.28%
FCF Conversion (EBITDA) - - - - - - - 9.06%
FCF Conversion (Net income) - - - - - - - 18.02%
Dividend per Share - - - - - - - -
Announcement Date 2/20/20 2/18/21 2/17/22 2/15/23 2/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 31.48 38.41 45.64 36.71 59.61 45.59 48.16 60.76 84.22 94.5 99.32 102.6 98.91 118.2 131.6
EBITDA 1 -12.15 -14.67 -18.32 -23.19 -4.464 -13.94 -10.83 -7.295 9.132 12.93 14.94 16.41 15.18 26.08 32.21
EBIT 1 -16.31 -18.62 -22.65 -28.31 -9.666 -18.91 -17.04 -14.63 1.383 5.138 4.732 4.672 2.836 10.8 14.6
Operating Margin -51.83% -48.49% -49.62% -77.12% -16.22% -41.48% -35.39% -24.09% 1.64% 5.44% 4.76% 4.55% 2.87% 9.14% 11.1%
Earnings before Tax (EBT) 1 -16.35 -19.48 -24.05 -29.6 -9.609 -16.8 -15.42 -13.07 -0.519 -1.079 3.144 3.074 0.7368 8.1 11.8
Net income 1 -16.35 -19.48 -24.05 -29.6 -9.609 -16.8 -15.42 -13.07 -0.519 -1.835 3.223 3.271 0.6884 8.686 13.21
Net margin -51.96% -50.73% -52.7% -80.63% -16.12% -36.84% -32.03% -21.52% -0.62% -1.94% 3.25% 3.19% 0.7% 7.35% 10.04%
EPS 2 -0.5000 -0.5900 -0.6800 -0.7500 -0.2000 -0.2400 -0.2200 -0.1900 -0.0100 -0.0200 0.0433 0.0422 0.008890 0.0900 0.1450
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/17/22 4/27/22 7/27/22 10/26/22 2/15/23 5/3/23 8/2/23 11/1/23 2/12/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 38.7 328 431
Net Cash position 1 0.51 12.8 - - 24.7 - - -
Leverage (Debt/EBITDA) - - - - - 0.641 x 2.688 x 2.406 x
Free Cash Flow 1 -3.17 -13.3 -32.4 -272 -218 -53.1 -200 16.2
ROE (net income / shareholders' equity) -22.5% -34.4% -21.1% -28.9% -9.79% 3.35% 9.1% 10.2%
ROA (Net income/ Total Assets) -14.4% -21.7% -29.1% -19.9% -6.8% 4.45% 9.1% 5.4%
Assets 1 101.3 100.5 127.4 414.8 673.2 128.9 555.1 1,666
Book Value Per Share 2 2.430 2.440 4.220 11.30 6.380 6.650 7.410 8.000
Cash Flow per Share 2 -0.0400 -0.3800 -0.6100 -2.400 -0.6100 -0.2100 1.170 1.420
Capex 1 2.11 3.42 13.8 178 175 73.2 447 167
Capex / Sales 1.52% 3.41% 11.33% 98.67% 73.5% 18.5% 79.55% 23.45%
Announcement Date 2/20/20 2/18/21 2/17/22 2/15/23 2/12/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
27.59 USD
Average target price
27.5 USD
Spread / Average Target
-0.33%
Consensus
  1. Stock Market
  2. Equities
  3. ASPN Stock
  4. Financials Aspen Aerogels, Inc.